Lexitas https://validator.w3.org/feed/docs/rss2.html Our Team Inside Look: Patient Retention in Ophthalmic Clinical Trials Speeding Ophthalmic Trial Execution with an In-House Reading Center Inside Look: Lexitas’ Best Corrected Visual Acuity Certification Program Lexitas CEO Jeanne Hecht On Trends And Challenges In Ophthalmology Clinical Trials J.P. Morgan Takeaways with Jeanne Hecht Lanita Scott, M.D. – Maximizing the Likelihood of Success for Your Ophthalmology Clinical Trials Inside Look: Enrollment Rates in Ophthalmic Clinical Trials AI Helps Identify Patients Likely to Respond to Treatment During Ophthalmology Clinical Trials Lexitas Pharma Services Welcomes Dr. David Tanzer as Chief Medical Officer Clinical Trials at the Summit Contact Reading Center About For Sponsors Our Plans to Help Bring More Ophthalmic Treatments to Patients Home Resources Five Key Considerations When Selecting an Ophthalmology CRO Inside Look Podcast Series Why Expertise in Ophthalmic Clinical Trials Matters for Medical and Protocol Writing  For Sites Amber Ophthalmics Benefits From Image Reading Center To Develop New Treatment Options For PCED Building and Sustaining a Strong Company Culture Board of Directors Operationalizing an Ophthalmology Protocol Development In Virtual Reality Testing As A Standardized Clinical End Point (via Modern Retina) A Deeper Look at Pegcetacoplan (via Optometry Times Journal) The State of the Ophthalmology Funding Landscape Using AI in the Development of New Ophthalmic Treatment Trends in Ophthalmology Clinical Trials (Video) What The Best Ophthalmology Sponsors Do Differently? Best-Corrected Visual Acuity Testing In Clinical Practice and Clinical Trials Shawn Scranton, PharmD., on Revolutionizing the Treatment of Ophthalmic Diseases Advisory Board Finding Quality Clinical Research Sites Careers The Future Of Decentralized Clinical Trials In Ophthalmology Choosing a CRO – Avoiding the Trap of Commoditization One Size Fits None – Internal Focus at the Expense of Customer Relationships Lexitas Monitors – Focused on Details and the Big Picture How Diversity, Equity and Inclusion in Clinical Trials Leads to Better Health Outcomes All Under One Roof The Hidden Value of Onsite Monitoring Achieving Repeatability in Staining with a Modified NEI Scale How Allgenesis Evaluated Unique Endpoints to Advance its Phase How Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech The Impact of Contact Lens Wear On the Ocular Surface w/ Dr. Joe Shovlin From Patient Care to Research: Dr. Bruce Segal’s Journey with Ophthalmic Drug Approval Lifestyle Impact On Ocular Health w/ Dr. Sheetal Shah